AMAG Pharma (AMAG) Misses Q1 EPS by 17c; Reiterates Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LITE
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. SPY

Go back to AMAG Pharma (AMAG) Misses Q1 EPS by 17c; Reiterates Outlook

AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results

May 3, 2016 7:01 AM EDT

First quarter 2016 non-GAAP product revenue increased 52% to $117.6 million1Entered into new Makena® partnership with a leading provider of home nursing services

Conference call scheduled for 8:00 a.m. ET today

WALTHAM, Mass., May 03, 2016 (GLOBE NEWSWIRE) --  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a specialty pharmaceutical company with a diverse portfolio of products in the areas of maternal health, anemia management and cancer supportive care, today reported unaudited consolidated financial results for the first quarter ended March 31, 2016.

Most notably, the first quarter of 2016 included... More